GlobeNewsWire
15 Dec 2025, 21:51 UTC · 45w ago
Verdict
Headline takes no side. We score CLLS +0.30 — moderately bullish.
+0.30moderately bullish
More positive than 59% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
Continue reading
5 related stories
More positive than 34% of relationship scores this week
[mutual] Cellectis is required to engage in discussions regarding the granting of a direct license for product UCART19 V1 to Allogene.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
3d ago
−77.5%
Price is moving against the score
$1.08 vs $4.79 close before publication (Dec 15) · not market-adjusted
CLLS chart →
